Nickie Andescavage1, Alexa Yarish2, Mary Donofrio3, Dorothy Bulas2, Iordanis Evangelou4, Gilbert Vezina5, Robert McCarter6, Adre duPlessis7, Catherine Limperopoulos8. 1. Division of Neonatology, Children's National Health Systems, 111 Michigan Ave. NW, Washington, DC 20010, United States; Department of Pediatrics, George Washington University School of Medicine, 2300 Eye St. NW, Washington, DC 20037, United States. 2. Division of Diagnostic Imaging & Radiology, Children's National Health Systems, 111 Michigan Ave. NW, Washington, DC 20010, United States. 3. Division of Cardiology, Children's National Health Systems, 111 Michigan Ave. NW, Washington, DC 20010, United States. 4. Division of Diagnostic Imaging & Radiology, Children's National Health Systems, 111 Michigan Ave. NW, Washington, DC 20010, United States; Division of Fetal & Transitional Medicine, Children's National Health Systems, 111 Michigan Ave. NW, Washington, DC 20010, United States; Department of Radiology, George Washington University School of Medicine, 2300 Eye St. NW, Washington, DC 20037, United States. 5. Division of Diagnostic Imaging & Radiology, Children's National Health Systems, 111 Michigan Ave. NW, Washington, DC 20010, United States; Department of Radiology, George Washington University School of Medicine, 2300 Eye St. NW, Washington, DC 20037, United States. 6. Division of Biostatistics & Informatics, Children's National Health Systems, 111 Michigan Ave. NW, Washington, DC 20010, United States. 7. Division of Fetal & Transitional Medicine, Children's National Health Systems, 111 Michigan Ave. NW, Washington, DC 20010, United States; Department of Pediatrics, George Washington University School of Medicine, 2300 Eye St. NW, Washington, DC 20037, United States. 8. Division of Diagnostic Imaging & Radiology, Children's National Health Systems, 111 Michigan Ave. NW, Washington, DC 20010, United States; Division of Fetal & Transitional Medicine, Children's National Health Systems, 111 Michigan Ave. NW, Washington, DC 20010, United States; Department of Radiology, George Washington University School of Medicine, 2300 Eye St. NW, Washington, DC 20037, United States. Electronic address: climpero@childrensnational.org.
Abstract
INTRODUCTION: Placental insufficiency remains a common cause of perinatal mortality and neurodevelopmental morbidity. Congenital heart disease (CHD) in the fetus and its relationship to placental function is unknown. This study explores placental health and its relationship to neonatal outcomes by comparing placental volumes in healthy pregnancies and pregnancies complicated by CHD using in vivo three-dimensional MRI studies. METHODS: In a prospective observational study, pregnant women greater than 18 weeks gestation with normal pregnancies or pregnancies complicated by CHD were recruited and underwent fetal MR imaging. The placenta was manually outlined and the volume was calculated in cm(3). Brain volume was also calculated and clinical data were also collected. Relationships, including interactive effects, between placental and fetal growth, including brain growth, were evaluated using longitudinal multiple linear regression analysis. RESULTS: 135 women underwent fetal MRI between 18 and 39 weeks gestation (mean 31.6 ± 4.4). Placental volume increased exponentially with gestational age (p = 0.041). Placental volume was positively associated with birth weight (p < 0.001) and increased more steeply with birth weight in CHD-affected fetuses (p = 0.046). Total brain and cerebral volumes were smaller in the CHD group (p < 0.001), but brainstem volume (p < 0.001) was larger. Placental volumes were not associated with brain volumes. DISCUSSION: Impaired placental growth in CHD is associated with gestational age and birth weight at delivery. Abnormalities in placental development may contribute to the significant morbidity in this high-risk population. Assessment of placental volume by MRI allows for in vivo assessments of placental development.
INTRODUCTION:Placental insufficiency remains a common cause of perinatal mortality and neurodevelopmental morbidity. Congenital heart disease (CHD) in the fetus and its relationship to placental function is unknown. This study explores placental health and its relationship to neonatal outcomes by comparing placental volumes in healthy pregnancies and pregnancies complicated by CHD using in vivo three-dimensional MRI studies. METHODS: In a prospective observational study, pregnant women greater than 18 weeks gestation with normal pregnancies or pregnancies complicated by CHD were recruited and underwent fetal MR imaging. The placenta was manually outlined and the volume was calculated in cm(3). Brain volume was also calculated and clinical data were also collected. Relationships, including interactive effects, between placental and fetal growth, including brain growth, were evaluated using longitudinal multiple linear regression analysis. RESULTS: 135 women underwent fetal MRI between 18 and 39 weeks gestation (mean 31.6 ± 4.4). Placental volume increased exponentially with gestational age (p = 0.041). Placental volume was positively associated with birth weight (p < 0.001) and increased more steeply with birth weight in CHD-affected fetuses (p = 0.046). Total brain and cerebral volumes were smaller in the CHD group (p < 0.001), but brainstem volume (p < 0.001) was larger. Placental volumes were not associated with brain volumes. DISCUSSION: Impaired placental growth in CHD is associated with gestational age and birth weight at delivery. Abnormalities in placental development may contribute to the significant morbidity in this high-risk population. Assessment of placental volume by MRI allows for in vivo assessments of placental development.
Authors: C Clouchoux; A J du Plessis; M Bouyssi-Kobar; W Tworetzky; D B McElhinney; D W Brown; A Gholipour; D Kudelski; S K Warfield; R J McCarter; R L Robertson; A C Evans; J W Newburger; C Limperopoulos Journal: Cereb Cortex Date: 2012-09-12 Impact factor: 5.357
Authors: Jodi L Pawluski; Susanne Brummelte; Cindy K Barha; Tamara M Crozier; Liisa A M Galea Journal: Front Neuroendocrinol Date: 2009-04-08 Impact factor: 8.606
Authors: N H P Claessens; N Khalili; I Isgum; H Ter Heide; T J Steenhuis; E Turk; N J G Jansen; L S de Vries; J M P J Breur; R de Heus; M J N L Benders Journal: AJNR Am J Neuroradiol Date: 2019-03-28 Impact factor: 3.825
Authors: Patrick Y Jay; Ehiole Akhirome; Rachel A Magnan; M Rebecca Zhang; Lillian Kang; Yidan Qin; Nelson Ugwu; Suk Dev Regmi; Julie M Nogee; James M Cheverud Journal: Mol Cell Endocrinol Date: 2016-08-20 Impact factor: 4.102
Authors: Jill J Savla; Mary E Putt; Jing Huang; Samuel Parry; Julie S Moldenhauer; Samantha Reilly; Olivia Youman; Jack Rychik; Laura Mercer-Rosa; J William Gaynor; Steven M Kawut Journal: J Am Heart Assoc Date: 2022-01-11 Impact factor: 6.106
Authors: David F A Lloyd; Joshua F P van Amerom; Kuberan Pushparajah; John M Simpson; Vita Zidere; Owen Miller; Gurleen Sharland; Joanna Allsop; Matthew Fox; Maelene Lohezic; Maria Murgasova; Christina Malamateniou; Jo V Hajnal; Mary Rutherford; Reza Razavi Journal: Prenat Diagn Date: 2016-08-31 Impact factor: 3.050